IR contributes to tumor progression by generating truncated oncogenic proteins, suppressing tumor suppressor genes like TIMP1 and DMD, and enabling cancer cells to adapt to stressors like hypoxia [47,121,122,123]. The gene discussed is TIMP1; the disease is cancer.